IBRISAR Trademark

Trademark Overview

On Thursday, April 29, 2004, a trademark application was filed for IBRISAR with the United States Patent and Trademark Office. The USPTO has given the IBRISAR trademark a serial number of 78410116. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 27, 2008. This trademark is owned by AstraZeneca AB. The IBRISAR trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS
ibrisar

General Information

Serial Number78410116
Word MarkIBRISAR
Filing DateThursday, April 29, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 27, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2005

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 5, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE 151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE 151 85
SE

Trademark Events

Event DateEvent Description
Monday, October 27, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 27, 2008ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 20, 2008EXTENSION 5 GRANTED
Tuesday, March 4, 2008EXTENSION 5 FILED
Tuesday, March 4, 2008TEAS EXTENSION RECEIVED
Thursday, October 4, 2007EXTENSION 4 GRANTED
Tuesday, September 25, 2007EXTENSION 4 FILED
Tuesday, September 25, 2007TEAS EXTENSION RECEIVED
Monday, July 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 14, 2007EXTENSION 3 GRANTED
Thursday, March 1, 2007EXTENSION 3 FILED
Thursday, March 1, 2007TEAS EXTENSION RECEIVED
Thursday, June 8, 2006EXTENSION 2 GRANTED
Thursday, June 8, 2006EXTENSION 2 FILED
Thursday, June 8, 2006TEAS EXTENSION RECEIVED
Wednesday, April 12, 2006EXTENSION 1 GRANTED
Monday, March 27, 2006EXTENSION 1 FILED
Monday, March 27, 2006TEAS EXTENSION RECEIVED
Tuesday, September 27, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Sunday, August 14, 2005EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, April 8, 2005EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 15, 2005PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2005NOTICE OF PUBLICATION
Thursday, December 9, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 3, 2004ASSIGNED TO LIE
Saturday, November 27, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 27, 2004ASSIGNED TO EXAMINER
Wednesday, May 5, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

ibrisar cardiovascular diseases disorders treatment prevention preparations substances pharmaceutical